Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03114891 · ClinicalTrials.gov registry record · NA
Accelerated TMS to a Novel Brain Target in MDD and PTSD
A NA study, sponsored by University of Pennsylvania.
- Completed
- Registry status
- NA
- Development phase
- 50
- Enrollment target
NCT03114891: Completed NA study, sponsored by University of Pennsylvania.
NCT03114891 is a NA study that has completed, run by University of Pennsylvania. The registered enrollment target is 50 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03114891, a NA study, has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
Study Summary
This is a Clinical Trial designed to evaluate novel transcranial magnetic stimulation (TMS) methods for treating depression/PTSD. TMS is an FDA-approved procedure for treatment-resistant depression. The use of the stimulation in this current study is considered experimental. The purpose of this research study is to compare the effects of TMS at two different brain regions. This information will help the investigators to determine which treatment strategies provide the greatest clinical benefit to patients. Results of the study will provide brain and behavior measures for future work, which may be critical to developing effective disease markers and novel treatments for psychiatric conditions.
Interventions
- DEVICE Transcranial Magnetic Stimulation (TMS)
- BEHAVIORAL Task
- PROCEDURE fMRI-guided TMS target
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2017-04-20 |
| Est. Completion | 2021-12-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03114891
The ClinicalTrials.gov registry entry for NCT03114891 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Transcranial Magnetic Stimulation (TMS) is the first listed.
NCT03114891 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03114891 about?
NCT03114891 is a clinical study titled "Accelerated TMS to a Novel Brain Target in MDD and PTSD". This is a Clinical Trial designed to evaluate novel transcranial magnetic stimulation (TMS) methods for treating depression/PTSD. TMS is an FDA-approved procedure for treatment-resistant depression. The use of the stimulation in this current study is considered experimental. The purpose of this rese...
What is the current status of trial NCT03114891?
This trial is currently completed. It is a NA study. The enrollment target is 50 participants. The study started on 2017-04-20. Estimated completion is 2021-12-01.
What interventions are being tested in trial NCT03114891?
The interventions under investigation include: Transcranial Magnetic Stimulation (TMS) (DEVICE), Task (BEHAVIORAL), fMRI-guided TMS target (PROCEDURE).
Who is sponsoring clinical trial NCT03114891?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.